Annual Operating Profit
-$219.22 M
-$90.10 M-69.78%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual operating income is -$219.22 million, with the most recent change of -$90.10 million (-69.78%) on December 31, 2023.
- During the last 3 years, INBX annual operating profit has fallen by -$151.78 million (-225.05%).
- INBX annual operating profit is now -1011.22% below its all-time high of -$19.73 million, reached on December 31, 2017.
Performance
INBX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$46.80 M
+$114.10 M+70.92%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly operating income is -$46.80 million, with the most recent change of +$114.10 million (+70.92%) on September 30, 2024.
- Over the past year, INBX quarterly operating profit has increased by +$114.10 million (+70.92%).
- INBX quarterly operating profit is now -1195.60% below its all-time high of -$3.61 million, reached on March 31, 2019.
Performance
INBX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$278.72 M
-$970.00 K-0.35%
September 30, 2024
Summary
- As of February 8, 2025, INBX TTM operating income is -$278.72 million, with the most recent change of -$970.00 thousand (-0.35%) on September 30, 2024.
- Over the past year, INBX TTM operating profit has dropped by -$970.00 thousand (-0.35%).
- INBX TTM operating profit is now -3032.79% below its all-time high of -$8.90 million, reached on March 31, 2018.
Performance
INBX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
INBX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -69.8% | +70.9% | -0.3% |
| 3 y3 years | -225.1% | -18.4% | -99.6% |
| 5 y5 years | -642.8% | -18.4% | -99.6% |
INBX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -186.3% | at low | -141.2% | +70.9% | -264.0% | at low |
| 5 y | 5-year | -401.5% | at low | -200.8% | +70.9% | -537.6% | at low |
| alltime | all time | -1011.2% | at low | -1195.6% | +70.9% | -3032.8% | at low |
Inhibrx Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$46.80 M(-70.9%) | -$278.72 M(+0.3%) |
| Jun 2024 | - | -$160.90 M(+226.9%) | -$277.75 M(+75.6%) |
| Mar 2024 | - | -$49.21 M(+125.6%) | -$158.19 M(+6.5%) |
| Dec 2023 | -$219.22 M(+69.8%) | -$21.82 M(-52.4%) | -$148.52 M(-8.4%) |
| Sep 2023 | - | -$45.83 M(+10.9%) | -$162.21 M(+10.8%) |
| Jun 2023 | - | -$41.34 M(+4.5%) | -$146.38 M(+4.8%) |
| Mar 2023 | - | -$39.54 M(+11.4%) | -$139.64 M(+8.2%) |
| Dec 2022 | -$129.12 M(+68.6%) | -$35.50 M(+18.3%) | -$129.12 M(+14.2%) |
| Sep 2022 | - | -$30.00 M(-13.3%) | -$113.02 M(+11.0%) |
| Jun 2022 | - | -$34.60 M(+19.2%) | -$101.82 M(+17.0%) |
| Mar 2022 | - | -$29.02 M(+49.5%) | -$87.02 M(+13.7%) |
| Dec 2021 | -$76.56 M | -$19.40 M(+3.2%) | -$76.56 M(+3.1%) |
| Sep 2021 | - | -$18.80 M(-5.1%) | -$74.27 M(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$19.80 M(+6.7%) | -$71.02 M(+3.9%) |
| Mar 2021 | - | -$18.56 M(+8.5%) | -$68.39 M(+1.4%) |
| Dec 2020 | -$67.44 M(+54.3%) | -$17.11 M(+10.0%) | -$67.44 M(+1.0%) |
| Sep 2020 | - | -$15.56 M(-9.4%) | -$66.79 M(+3.9%) |
| Jun 2020 | - | -$17.17 M(-2.5%) | -$64.28 M(+11.4%) |
| Mar 2020 | - | -$17.61 M(+7.0%) | -$57.71 M(+32.0%) |
| Dec 2019 | -$43.71 M(+48.1%) | -$16.45 M(+26.1%) | -$43.71 M(+60.4%) |
| Sep 2019 | - | -$13.05 M(+23.1%) | -$27.26 M(+91.8%) |
| Jun 2019 | - | -$10.60 M(+193.5%) | -$14.21 M(+38.2%) |
| Mar 2019 | - | -$3.61 M(-45.9%) | -$10.29 M(-33.9%) |
| Dec 2018 | -$29.51 M(+49.6%) | - | - |
| Jun 2018 | - | -$6.67 M(-25.0%) | -$15.57 M(+75.0%) |
| Mar 2018 | - | -$8.90 M | -$8.90 M |
| Dec 2017 | -$19.73 M | - | - |
FAQ
- What is Inhibrx Biosciences annual operating income?
- What is the all time high annual operating profit for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual operating profit year-on-year change?
- What is Inhibrx Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly operating profit year-on-year change?
- What is Inhibrx Biosciences TTM operating income?
- What is the all time high TTM operating profit for Inhibrx Biosciences?
- What is Inhibrx Biosciences TTM operating profit year-on-year change?
What is Inhibrx Biosciences annual operating income?
The current annual operating profit of INBX is -$219.22 M
What is the all time high annual operating profit for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual operating income is -$19.73 M
What is Inhibrx Biosciences annual operating profit year-on-year change?
Over the past year, INBX annual operating income has changed by -$90.10 M (-69.78%)
What is Inhibrx Biosciences quarterly operating income?
The current quarterly operating profit of INBX is -$46.80 M
What is the all time high quarterly operating profit for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly operating income is -$3.61 M
What is Inhibrx Biosciences quarterly operating profit year-on-year change?
Over the past year, INBX quarterly operating income has changed by +$114.10 M (+70.92%)
What is Inhibrx Biosciences TTM operating income?
The current TTM operating profit of INBX is -$278.72 M
What is the all time high TTM operating profit for Inhibrx Biosciences?
Inhibrx Biosciences all-time high TTM operating income is -$8.90 M
What is Inhibrx Biosciences TTM operating profit year-on-year change?
Over the past year, INBX TTM operating income has changed by -$970.00 K (-0.35%)